Therapeutic Effect of Ethanol-gelfoam Mixture for the Treatment of Arterioportal Shunts (APS) in Patients With HCC

PHASE3UnknownINTERVENTIONAL

Enrollment

236

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

December 31, 2017

Conditions

Carcinoma, Hepatocellular

Interventions

PROCEDURE

TACE

Transarterial chemoembolisation (TACE)

DRUG

EGM

Occlude arterioportal shunts(APS) with ethanol/gelfoam mixture(EGM)

DRUG

PVA

Occlude arterioportal shunts(APS) with PVA

Trial Locations (2)

RECRUITING

The First Affiliated Hospital of Nanjing Medical University, Nanjing

RECRUITING

Zhong da hospital, Southeast university, Nanjing